Zappia V - Search Results

1

Metabolic consequences of hyperhomocysteinemia in uremia.

Perna AF, Ingrosso D, Satta E, Romano M, Cimmino A, Galletti P, Zappia V, De Santo NG. Perna AF, et al. Among authors: zappia v. Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S85-90. doi: 10.1053/ajkd.2001.27411. Am J Kidney Dis. 2001. PMID: 11576929 Review.

2

Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia.

Ingrosso D, Cimmino A, Perna AF, Masella L, De Santo NG, De Bonis ML, Vacca M, D'Esposito M, D'Urso M, Galletti P, Zappia V. Ingrosso D, et al. Among authors: zappia v. Lancet. 2003 May 17;361(9370):1693-9. doi: 10.1016/S0140-6736(03)13372-7. Lancet. 2003. PMID: 12767735 Clinical Trial.

3

Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia.

Perna AF, Ingrosso D, De Santo NG, Galletti P, Zappia V. Perna AF, et al. Among authors: zappia v. Kidney Int. 1995 Jan;47(1):247-53. doi: 10.1038/ki.1995.31. Kidney Int. 1995. PMID: 7731153 Free article.

4

Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia.

Perna AF, Ingrosso D, De Santo NG, Galletti P, Brunone M, Zappia V. Perna AF, et al. Among authors: zappia v. J Am Soc Nephrol. 1997 Dec;8(12):1899-905. doi: 10.1681/ASN.V8121899. J Am Soc Nephrol. 1997. PMID: 9402092 Clinical Trial.

5

Homocysteine, a new crucial element in the pathogenesis of uremic cardiovascular complications.

Perna AF, Ingrosso D, Castaldo P, De Santo NG, Galletti P, Zappia V. Perna AF, et al. Among authors: zappia v. Miner Electrolyte Metab. 1999 Jan-Apr;25(1-2):95-9. doi: 10.1159/000057428. Miner Electrolyte Metab. 1999. PMID: 10207268 Review.

6

Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: implications for mechanism.

Perna AF, Castaldo P, De Santo NG, di Carlo E, Cimmino A, Galletti P, Zappia V, Ingrosso D. Perna AF, et al. Among authors: zappia v. Kidney Int. 2001 Jun;59(6):2299-308. doi: 10.1046/j.1523-1755.2001.00747.x. Kidney Int. 2001. PMID: 11380834 Free article.

7

Protein methylation as a marker of aspartate damage in glucose-6-phosphate dehydrogenase-deficient erythrocytes: role of oxidative stress.

Ingrosso D, Cimmino A, D'Angelo S, Alfinito F, Zappia V, Galletti P. Ingrosso D, et al. Among authors: zappia v. Eur J Biochem. 2002 Apr;269(8):2032-9. doi: 10.1046/j.1432-1033.2002.02838.x. Eur J Biochem. 2002. PMID: 11985579 Free article.

8

Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.

Adinolfi LE, Ingrosso D, Cesaro G, Cimmino A, D'Antò M, Capasso R, Zappia V, Ruggiero G. Adinolfi LE, et al. Among authors: zappia v. Hepatology. 2005 May;41(5):995-1003. doi: 10.1002/hep.20664. Hepatology. 2005. PMID: 15834927

9

Increased membrane-protein methylation in hereditary spherocytosis. A marker of cytoskeletal disarray.

Ingrosso D, D'Angelo S, Perna AF, Iolascon A, Miraglia del Giudice E, Perrotta S, Zappia V, Galletti P. Ingrosso D, et al. Among authors: zappia v. Eur J Biochem. 1995 Mar 15;228(3):894-8. doi: 10.1111/j.1432-1033.1995.tb20337.x. Eur J Biochem. 1995. PMID: 7737191 Free article.

10

Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine.

Perna AF, Ingrosso D, Zappia V, Galletti P, Capasso G, De Santo NG. Perna AF, et al. Among authors: zappia v. J Clin Invest. 1993 Jun;91(6):2497-503. doi: 10.1172/JCI116485. J Clin Invest. 1993. PMID: 8514862 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters